In this issue of Surgical Oncology Clinics, guest editor Dr. Jashodeep Datta brings his considerable expertise to the topic of Immunotherapy for Solid Tumors. Immunotherapy for solid tumors represents a transformative approach in the field of oncology, and has potential to offer durable responses and long-term remission, even in cancers that have been resistant to conventional therapies. This issue provides a contemporary appraisal of advances in immunotherapy technologies and applications for solid tumors, particularly as they related to the surgical management of these diseases.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. xi 7. Foreword - p. xiii 8. Preface - p. xv 9. T-Cell Receptor Engineered T-Cell Therapy: A Rapidly Evolving Treatment Paradigm for Solid Tumors - p. 191 10. CAR T-Cell Therapy for Solid Tumors: Clinical Challenges and Current Advancements - p. 207 11. Response-Based Immunotherapy in Melanoma: A New Paradigm - p. 223 12. Combining Systemic and Local/Regional Approaches to Improve Immunotherapy Sensitivity - p. 237 13. Disrupting the Immunosuppressive Myeloid Compartment in Solid Tumors - p. 251 14. Dendritic Cell-Based Immunotherapy for Solid Tumors - p. 271 15. Leveraging the Human Microbiome to Improve Immunotherapy Sensitivity - p. 285 16. mRNA Vaccines for Cancer Treatment - p. 299 17. Biomarkers of Immunotherapy Response in Surgical Oncology - p. 317 18. Identifying Subsets of Patients with Non-immunogenic Gastrointestinal Cancers for Checkpoint Immunotherapy - p. 347 19. B-cell–directed Immunotherapy for Solid Tumors - p. 367 20. Oncolytic Virotherapy for Solid Tumors: Clinical Advances and Future Directions - p. 385 21. Utility of Circulating Tumor DNA-Based Liquid Biopsies in Patients with Cancer Receiving Immunotherapy - p. 399 22. Contemporary Management of Immune Checkpoint Inhibitor-related Adverse Events - p. 415
In this issue of Surgical Oncology Clinics, guest editor Dr. Jashodeep Datta brings his considerable expertise to the topic of Immunotherapy for Solid Tumors. Immunotherapy for solid tumors represents a transformative approach in the field of oncology, and has potential to offer durable responses and long-term remission, even in cancers that have been resistant to conventional therapies. This issue provides a contemporary appraisal of advances in immunotherapy technologies and applications for solid tumors, particularly as they related to the surgical management of these diseases.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. xi 7. Foreword - p. xiii 8. Preface - p. xv 9. T-Cell Receptor Engineered T-Cell Therapy: A Rapidly Evolving Treatment Paradigm for Solid Tumors - p. 191 10. CAR T-Cell Therapy for Solid Tumors: Clinical Challenges and Current Advancements - p. 207 11. Response-Based Immunotherapy in Melanoma: A New Paradigm - p. 223 12. Combining Systemic and Local/Regional Approaches to Improve Immunotherapy Sensitivity - p. 237 13. Disrupting the Immunosuppressive Myeloid Compartment in Solid Tumors - p. 251 14. Dendritic Cell-Based Immunotherapy for Solid Tumors - p. 271 15. Leveraging the Human Microbiome to Improve Immunotherapy Sensitivity - p. 285 16. mRNA Vaccines for Cancer Treatment - p. 299 17. Biomarkers of Immunotherapy Response in Surgical Oncology - p. 317 18. Identifying Subsets of Patients with Non-immunogenic Gastrointestinal Cancers for Checkpoint Immunotherapy - p. 347 19. B-cell–directed Immunotherapy for Solid Tumors - p. 367 20. Oncolytic Virotherapy for Solid Tumors: Clinical Advances and Future Directions - p. 385 21. Utility of Circulating Tumor DNA-Based Liquid Biopsies in Patients with Cancer Receiving Immunotherapy - p. 399 22. Contemporary Management of Immune Checkpoint Inhibitor-related Adverse Events - p. 415
